Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 71

Cited In for PubMed (Select 15557506)

1.

Vascular function, cerebral cortical thickness, and cognitive performance in middle-aged Hispanic and non-Hispanic caucasian adults.

Pasha EP, Kaur SS, Gonzales MM, Machin DR, Kasischke K, Tanaka H, Haley AP.

J Clin Hypertens (Greenwich). 2015 Apr;17(4):306-12. doi: 10.1111/jch.12512. Epub 2015 Feb 26.

PMID:
25720950
2.

Coronary artery disease and plasma apolipoprotein E4 in mild cognitive impairment.

Barekatain M, Zahedian F, Askarpour H, Maracy MR, Hashemi-Jazi M, Aghaye-Ghazvini MR.

ARYA Atheroscler. 2014 Sep;10(5):244-51.

3.

Obesity and cognitive decline: role of inflammation and vascular changes.

Nguyen JC, Killcross AS, Jenkins TA.

Front Neurosci. 2014 Nov 19;8:375. doi: 10.3389/fnins.2014.00375. eCollection 2014. Review.

4.
5.

Early life instruction in foreign language and music and incidence of mild cognitive impairment.

Wilson RS, Boyle PA, Yang J, James BD, Bennett DA.

Neuropsychology. 2015 Mar;29(2):292-302. doi: 10.1037/neu0000129. Epub 2014 Aug 11.

PMID:
25110933
6.

Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis.

Beydoun MA, Beydoun HA, Gamaldo AA, Teel A, Zonderman AB, Wang Y.

BMC Public Health. 2014 Jun 24;14:643. doi: 10.1186/1471-2458-14-643.

7.

Autonomic dysfunction in mild cognitive impairment: evidence from power spectral analysis of heart rate variability in a cross-sectional case-control study.

Nicolini P, Ciulla MM, Malfatto G, Abbate C, Mari D, Rossi PD, Pettenuzzo E, Magrini F, Consonni D, Lombardi F.

PLoS One. 2014 May 6;9(5):e96656. doi: 10.1371/journal.pone.0096656. eCollection 2014.

8.

Vascular disease and risk factors are associated with cognitive decline in the alzheimer disease spectrum.

Lorius N, Locascio JJ, Rentz DM, Johnson KA, Sperling RA, Viswanathan A, Marshall GA; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimer Dis Assoc Disord. 2015 Jan-Mar;29(1):18-25. doi: 10.1097/WAD.0000000000000043.

9.

Mild cognitive impairment: a concept in evolution.

Petersen RC, Caracciolo B, Brayne C, Gauthier S, Jelic V, Fratiglioni L.

J Intern Med. 2014 Mar;275(3):214-28. doi: 10.1111/joim.12190.

10.

Cognitive dysfunction and greater visit-to-visit systolic blood pressure variability.

Epstein NU, Lane KA, Farlow MR, Risacher SL, Saykin AJ, Gao S; Alzheimer's Disease Neuroimaging Initiative.

J Am Geriatr Soc. 2013 Dec;61(12):2168-73.

11.

Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences.

Mielke MM, Vemuri P, Rocca WA.

Clin Epidemiol. 2014 Jan 8;6:37-48. doi: 10.2147/CLEP.S37929. eCollection 2014. Review.

12.

Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal.

Roberts RO, Knopman DS, Mielke MM, Cha RH, Pankratz VS, Christianson TJ, Geda YE, Boeve BF, Ivnik RJ, Tangalos EG, Rocca WA, Petersen RC.

Neurology. 2014 Jan 28;82(4):317-25. doi: 10.1212/WNL.0000000000000055. Epub 2013 Dec 18.

13.

Classification and epidemiology of MCI.

Roberts R, Knopman DS.

Clin Geriatr Med. 2013 Nov;29(4):753-72. doi: 10.1016/j.cger.2013.07.003. Review.

14.

Type 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies.

Kravitz E, Schmeidler J, Schnaider Beeri M.

Endocrinol Metab Clin North Am. 2013 Sep;42(3):489-501. doi: 10.1016/j.ecl.2013.05.009. Review.

15.

Estrogen: a master regulator of bioenergetic systems in the brain and body.

Rettberg JR, Yao J, Brinton RD.

Front Neuroendocrinol. 2014 Jan;35(1):8-30. doi: 10.1016/j.yfrne.2013.08.001. Epub 2013 Aug 29. Review.

16.

Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study.

Yasar S, Xia J, Yao W, Furberg CD, Xue QL, Mercado CI, Fitzpatrick AL, Fried LP, Kawas CH, Sink KM, Williamson JD, DeKosky ST, Carlson MC; Ginkgo Evaluation of Memory (GEM) Study Investigators.

Neurology. 2013 Sep 3;81(10):896-903. doi: 10.1212/WNL.0b013e3182a35228. Epub 2013 Aug 2.

17.

Mild cognitive impairment, incidence, progression, and reversion: findings from a community-based cohort of elderly African Americans.

Gao S, Unverzagt FW, Hall KS, Lane KA, Murrell JR, Hake AM, Smith-Gamble V, Hendrie HC.

Am J Geriatr Psychiatry. 2014 Jul;22(7):670-81. doi: 10.1016/j.jagp.2013.02.015. Epub 2013 Jul 3.

PMID:
23831172
18.

Perceived stress is associated with subclinical cerebrovascular disease in older adults.

Aggarwal NT, Clark CJ, Beck TL, Mendes de Leon CF, DeCarli C, Evans DA, Everson Rose SA.

Am J Geriatr Psychiatry. 2014 Jan;22(1):53-62. doi: 10.1016/j.jagp.2012.06.001. Epub 2013 Jan 9.

19.

Diabetes and the elderly brain: sweet memories?

Samaras K, Sachdev PS.

Ther Adv Endocrinol Metab. 2012 Dec;3(6):189-96. doi: 10.1177/2042018812469645.

20.

High blood pressure and cognitive decline in mild cognitive impairment.

Goldstein FC, Levey AI, Steenland NK.

J Am Geriatr Soc. 2013 Jan;61(1):67-73. doi: 10.1111/jgs.12067. Epub 2013 Jan 10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk